Canadian Cannabis Stocks Jump on Report U.S. May Move to Reclassify Marijuana

By Adriano Marchese


Canadian cannabis companies surged Wednesday after an Axios report said that the Trump Administration could move to reclassify marijuana.

Among the biggest gainers were Curaleaf Holdings, which rose 19% to 4.97 Canadian dollars ($3.64), while Tilray advanced by 9.5% to C$10.33. Canopy Growth was also up over 13% at C$1.77 and Aurora Cannabis increased by 7.4% to C$5.24.

The Trump administration is expected to reclassify cannabis as soon as Wednesday, Axios reported Wednesday, citing an administration official familiar with the matter.

In recent years, the U.S. has moved toward reclassifying marijuana by shifting it from the strict Schedule I category to a less restrictive Schedule III, driven by federal health recommendations and a 2025 executive order directing agencies to expedite the change.

The report said that the reclassification wouldn't immediately legalize marijuana, nor affect the sentences of individuals who were incarcerated for possessing it.


Write to Adriano Marchese at adriano.marchese@wsj.com


(END) Dow Jones Newswires

April 22, 2026 13:01 ET (17:01 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center